XML 63 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Restructuring Charges
3 Months Ended
Mar. 31, 2013
Restructuring Charges
15.
Restructuring Charges
 
In December 2012 the Company announced the closure of its tissue engineering facility in Abano Terme, Italy due to the inability to meet strict regulatory standards, effective January 1, 2013, established by the EMA for Advanced Therapy Medicinal Products. The restructuring plan involved a workforce reduction as well as associated asset abandonments. The Company recorded restructuring and impairment charges in the fourth quarter of 2012 of approximately $2.5 million. Of the total restructuring and impairment charges related to the tissue engineering operation, approximately $1.2 million related to the non-cash termination and related impairment of an IPR&D project, $0.3 million related to the disposal of property and equipment, and $0.1 million related to the disposal of inventory. The remaining $0.9 million relates to cash payments that are anticipated to occur in 2013, primarily for employee termination costs.

We made substantial progress in the first quarter of 2013 in completing the planned restructuring. During the current quarter, we sold certain previously impaired and written-off equipment resulting in a $135,607 restructuring credit recorded during the three months ended March 31, 2013. The carrying value of the restructuring accrual approximated fair value at March 31, 2013.

The following table summarizes restructuring accrual activity for the three months ended March 31, 2013:
 
   
2013 Restructuring Accrual
 
   
Employee Severance and Related Benefits
   
Activity Termination and Facility Closure Costs
   
Total
 
December 31, 2012
  $ 801,453     $ 132,279     $ 933,732  
Q1 2013 Charges to Operations
    -       -       -  
Cash Proceeds, Disbursements
    (587,662 )     (43,142 )     (630,804 )
Write Offs and Abandonments
    -       -       -  
Foreign Exchange Impact
    7,931       (281 )     7,650  
Restructuring Accrual - March 31, 2013
  $ 221,722     $ 88,856     $ 310,578